Question to the Department for Business, Energy and Industrial Strategy:

Her Majesty's Government, following the UK’s departure from Euratom, (1) whether they have any plans for molybdenum-99 to be produced in the UK; (2) whether design plans for nuclear reactors to produce molybdenum-99 have been approved and tendered; (3) what is the location of any new reactors located in the UK; (4) what is their assessment of how much such reactors will cost; and (5) what is the estimated unit cost of domestic production compared to current import prices.

Euratom places no restrictions on the export of medical isotopes to countries outside the EU. Such isotopes are not subject to Euratom Supply Agency contracts or to Euratom safeguards.